http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 06 Mar 2026 16:25:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Pauling+David/26125843.html si-local-file:///var/storage/secattach/20260306/26125843.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Pauling+David/26125843.html Fri, 06 Mar 2026 16:25:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Pauling+David/26125843.html si-local-file:///var/storage/secattach/20260306/26125843.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Pauling+David/26125843.html Fri, 06 Mar 2026 16:25:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Chung+Jane/26125785.html si-local-file:///var/storage/secattach/20260306/26125785.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Chung+Jane/26125785.html Fri, 06 Mar 2026 16:21:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Chung+Jane/26125785.html si-local-file:///var/storage/secattach/20260306/26125785.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+04++Filed+by%3A+Chung+Jane/26125785.html Fri, 06 Mar 2026 16:21:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Pauling+David/26104869.html si-local-file:///var/storage/secattach/20260303/26104869.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Pauling+David/26104869.html Tue, 03 Mar 2026 19:00:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Pauling+David/26104869.html si-local-file:///var/storage/secattach/20260303/26104869.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Pauling+David/26104869.html Tue, 03 Mar 2026 19:00:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Gerber+Hans-Peter/26104834.html si-local-file:///var/storage/secattach/20260303/26104834.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Gerber+Hans-Peter/26104834.html Tue, 03 Mar 2026 18:57:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Gerber+Hans-Peter/26104834.html si-local-file:///var/storage/secattach/20260303/26104834.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Gerber+Hans-Peter/26104834.html Tue, 03 Mar 2026 18:57:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+02++Filed+by%3A+Chow+Gregory+K./26104797.html si-local-file:///var/storage/secattach/20260303/26104797.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+02++Filed+by%3A+Chow+Gregory+K./26104797.html Tue, 03 Mar 2026 18:52:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+02++Filed+by%3A+Chow+Gregory+K./26104797.html si-local-file:///var/storage/secattach/20260303/26104797.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+02++Filed+by%3A+Chow+Gregory+K./26104797.html Tue, 03 Mar 2026 18:52:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Chung+Jane/26104766.html si-local-file:///var/storage/secattach/20260303/26104766.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Chung+Jane/26104766.html Tue, 03 Mar 2026 18:49:00 -0500 O.02325435 STRO http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Chung+Jane/26104766.html si-local-file:///var/storage/secattach/20260303/26104766.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++SUTRO+BIOPHARMA%2C+INC.+++++For%3A+Mar+01++Filed+by%3A+Chung+Jane/26104766.html Tue, 03 Mar 2026 18:49:00 -0500 O.02325435 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html <p>SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will participate in several upcoming investor conferences.</p> <p><strong>Conference Details:</strong></p> <p><strong>TD Cowen 46th Annual Health Care Conference </strong><br/><strong>Date:</strong> March 2-4, 2026<br/><strong>Location:</strong> Boston, MA<br/></p> <p><strong>Leerink Partners Global Healthcare Conference</strong><br/><strong>Date:</strong> March 8-11, 2026 <br/><strong>Location:</strong> Miami, FL</p> <p><strong>The Citizens Life Sciences Conference </strong><br/><strong>Date:</strong> March 10-11, 2026<br/><strong>Location: </strong>Miami, FL</p> <p><strong>Barclays 28th Annual Global Healthcare Conference</strong><br/><strong>Date:</strong> March 10-12, 2026<br/><strong>Location:</strong> Miami, FL</p> <p>Webcasts of the fireside chats at the TD http://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+to+Participate+in+Upcoming+Investor+Conferences/26055838.html Wed, 25 Feb 2026 08:30:00 -0500 A.50100012 A.50216399 O.02325435 O.07579093 O.22795517 STRO http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+Announces+Participation+at+the+16th+World+ADC+London+Summit/26039840.html <p align="left">SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced its participation at the 16th World ADC London Summit, taking place in London, UK, February 23-26, 2026.</p> <p><strong>Plenary/Panel Discussion Details:</strong></p> <ul><li><strong>Panel Discussion: ADC Licensing, Partnering &amp; Investment Session</strong> <ul><li>Sutro Participant: Hans-Peter Gerber, Ph.D.</li><li>Date/Time: February 23, 2026, 3:00PM GMT<br></br><br></br></li></ul> </li><li><strong>Panel Discussion: Evaluating the Cutting-Edge Innovation &amp; Performance Driving ADC Differentiation &amp; Progression Earlier Line Patient Therapies</strong><br></br> <ul><li>Sutro Participant: Hans-Peter Gerber, Ph.D.</li><li>Date/Time: February 24, http://www.streetinsider.com/Press+Releases/Sutro+Biopharma+Announces+Participation+at+the+16th+World+ADC+London+Summit/26039840.html Mon, 23 Feb 2026 08:30:00 -0500 A.50216399 O.02325435 O.22795517 STRO